U.S. stock analysts still too bullish, hurt investors


US securities analysts have been encouraged not to rate every company they cover as a Buy. That may not be working even as earnings fall.

According to the FT, "Equity research departments around the world have become much more bearish since the start of the year, but US analysts remain markedly more bullish on stocks than peers elsewhere." Research quoted by the paper shows that only 6.7% of stocks covered by U.S. stock researchers rate a Sell.

The news is disturbing because positive ratings are one of the things that keep investors in stocks and analysts who are slow to cut their price targets and modify opinions are likely to cost shareholder money.

U.S. stock researchers have long believed that lowering ratings gives them less access to management. That is a poor excuse for being overly bullish on shares.

The investing public and press mock analysts who put Sell ratings on stocks after they have dropped 90%. It appears that those actions are built into the U.S. equity research system.

Douglas A. McIntyre is an editor at 24/7 Wall St.

Symbol Lookup
IndexesChangePrice
DJIA+45.1412,846.37
NASDAQ+11.652,915.53
S&P 500+5.151,347.79

Last updated: February 13, 2012: 11:21 AM

Hot Stocks

General Electric

19.025+0.15(+0.79)

Alcoa

10.365+0.075(+0.73)

Apple Inc

499.99+6.57(+1.33)

Google Inc 'A'

612.55+6.64(+1.10)

Bank of America

8.265+0.195(+2.42)

Wal-Mart Stores

61.98+0.08(+0.13)

Exxon Mobil Corp

84.12+0.32(+0.38)

Ford

12.535+0.095(+0.76)

Citigroup

33.45+0.525(+1.59)

IBM

192.36-0.06(-0.03)

Yahoo

16.07-0.07(-0.43)

Starbucks

49.17+0.35(+0.72)

Microsoft

30.55+0.055(+0.18)

Home Depot

45.72+0.39(+0.86)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1329150117558 ms.